Q4 2018 Holdings
Filed 2019-02-14 | 17 holdings | $104.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $24.0K | 458,366 | 23.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $23.6K | 234,375 | 22.7% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $10.5K | 383,480 | 10.1% |
| Sutro BioPharma Inc | COM | 869367102 | $10.2K | 1,125,576 | 9.7% |
| Odonate Therapeutics Inc | COM | 676079106 | $8.4K | 595,850 | 8.1% |
| Liquidia Technologies Inc(LQDA) | COM | 53635D202 | $8.2K | 378,420 | 7.9% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $5.9K | 1,059,938 | 5.7% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $3.0K | 150,000 | 2.8% |
| Evelo Biosciences Inc | COM | 299734103 | $3.0K | 227,529 | 2.8% |
| Miragen Therapeutics Inc | COM | 60463E103 | $2.8K | 909,090 | 2.6% |
| Aravive Inc(VSAREUR) | COM | 03890D108 | $1.6K | 442,733 | 1.5% |
| Catabasis Pharmaceuticals Inc(CATBEUR) | COM | 14875P206 | $1.3K | 300,000 | 1.3% |
| Urovant Sciences Ltd | COM | G9381B108 | $1.0K | 157,480 | 1.0% |
| Millendo Therapeutics Inc | COM | 60040X103 | $359 | 45,101 | 0.3% |
| Surface Oncology Inc | COM | 86877M209 | $332 | 78,300 | 0.3% |
| Trillium Therapeutics Inc | COM | 89620X506 | $122 | 71,619 | 0.1% |
| Edge Therapeutics Inc | COM | 279870109 | $59 | 183,332 | 0.1% |